Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemics

Noninvasive mechanical ventilation in high risk infections, mass casualty and pandemics / Antonio M. Esquinas, editor.

Explains equipment and plan organization for health systems: how and when apply NIV, Presents a critical review analysis and practical implications, and Describes rationale, methodology, clinical results of NIMV in high risk infections and mass causalities.

Saved in:
Bibliographic Details
Other Authors: Esquinas, Antonio M.
Format: eBook
Language:English
Published: Cham : Springer, 2023.
Edition:Second edition.
Subjects:
Artificial respiration.
Lungs > Diseases > Treatment.
Emergency medicine.
Respiratory infections.
Online Access:Click for online access
Table of Contents:
  • Intro
  • Preface
  • Contents
  • Abbreviations
  • Part I: NIV and ARF: Overview, Transmission and Physiopathology, Equipment and Technologies
  • ARF Mechanical Ventilation and History in Pandemics
  • Introduction
  • Spanish Flu
  • Polio
  • Ebola
  • Future Perspectives and Conclusions
  • Conclusion
  • References
  • Hospital Organizations
  • Introduction
  • Organization
  • Laboratory and Diagnostic Imaging Services
  • Triage
  • Infection Control
  • Healthcare Workers
  • Recent TFMCC Recommendations for Staff Organization
  • Increasing ICU Bed Capacity
  • Management of Respiratory Failure
  • Maximize the Available Supply
  • Other Potential Solutions for Mechanical Ventilator Shortages
  • Conclusions
  • References
  • Noninvasive Ventilation in Patients with Infectious Diseases in the Emergency Room
  • Introduction
  • Is the NIV the First Option in Infectious Disease Patients?
  • NIV during the Influenza A (H1N1) Pandemic
  • NIV during the COVID-19 Pandemic
  • NIV and Immunodeficient Patient
  • Safety of Healthcare Professionals
  • References
  • Noninvasive Mechanical Ventilation After Chemical Disasters
  • Introduction
  • Analysis of Main Topics and Discussion
  • Nerve Agents
  • Vesicants
  • Cyanide
  • Pulmonary Agents
  • Riot Control Agents
  • Irritant Fume Exposure
  • Role of Noninvasive Mechanical Ventilation
  • Conclusion
  • References
  • Noninvasive Ventilation in Patients with Infectious Diseases Outside Intensive Care Unit
  • Introduction
  • The Necessity of Setting outside the ICU during a Pandemic
  • The Negative Pressure Rooms
  • Implications for Healthcare Worker
  • The Use of NIV in General Ward and Sub-Intensive Unit
  • Conclusion
  • References
  • Organization of a Noninvasive Mechanical Ventilation Unit for Immunocompromised Patients
  • Introduction
  • Immunocompromised Scenarios
  • Contraindications of NIV.
  • Hospital Resources Required for NIV
  • Personnel Responsible for NIV
  • Training
  • Monitoring of NIV
  • Administrative Participation
  • References
  • Transmission of Severe Acute Respiratory Syndrome During Intubation and Mechanical Ventilation
  • Introduction
  • Contamination Risk During Oxygen Therapy
  • Nasal Cannula and Oronasal Masks
  • Nebulizers, NIV, and HFNC
  • Contamination Risk During Invasive Ventilation
  • Contamination Risk During ECMO
  • Intubation-Related Contamination Risk
  • Healthcare Workers' Protective Equipment
  • Summary
  • References
  • The Rationale of Acute Respiratory Failure in High-Risk Infections
  • Introduction
  • High-Flow Nasal Oxygen (HFNC)
  • Use of HFNC Combined with Prone Positioning
  • Noninvasive Ventilation
  • Interface
  • Efficacy of NIV in Pulmonary Infections and Pandemics NIV in SARS
  • NIV in Influenza A H1N1 Infection
  • Tuberculosis
  • COVID-19
  • Aerosol Droplet Dispersion and Infection Risk Spread with NIV
  • High-Risk Infections and Healthcare Worker Protocols
  • Oxygen Therapy
  • Invasive Ventilation
  • Conclusion
  • References
  • Rationale of ARF Approach in Mass Causalities
  • Introduction
  • Discussion: Analysis
  • Conclusion
  • References
  • NIV-Pathophysiology-High-Risk Infection, Microbiology
  • Introduction
  • Discussion
  • References
  • Nasal High-Flow Oxygen Equipment
  • Introduction
  • HFNC: Accessories and Setting Up
  • Temperature Setting
  • Flow Rate Setting
  • Oxygen Setting
  • Monitoring
  • Bioaerosol Dispersion and Safe Distance During HFNC in Mass Infections
  • The Rationale for the Use of HFNC
  • Acute Hypoxemic Respiratory Failure (AHRF)
  • Acute Hypercapnic Respiratory Failure
  • Chronic Airway Disease
  • Avoidance of Intubation
  • HFNC and Preoxygenation
  • NFNC in the Post-Extubation
  • Palliative Care
  • HFNC Use in COVID-19 Patients
  • Conclusion
  • References.
  • NIV-CPAP Systems
  • Introduction
  • The History of NIV
  • CPAP: Physiology
  • Indications and Contraindications
  • Equipment and Mask Interface
  • Clinical Significance
  • Conclusion
  • References
  • NIV in High-Risk Infections, Mass Casualty, and Pandemics: What Interface?
  • Introduction
  • General Features of NIV Interface/Interface Choice Based on Type of Ventilator
  • Vented Mask
  • Non-vented Mask
  • NIV Interface and Potential Aerosol Production
  • Requisite for Ideal NIV Interface During High-Risk Airborne Infections
  • Types of Interfaces for NIV in High-Risk Infection Mass Casualties and Pandemics
  • Total Face Mask or Full-Face Mask
  • Helmets
  • Standard Face Mask/Oronasal Mask
  • Prevention and Management of Interface-Related Complications During High-Risk Airborne Infections
  • Air Leaks
  • Facial Skin Irritation or Pressure Sores
  • Oral or Nasal Dryness
  • Interface and Patient-Ventilator Asynchrony
  • Conclusion
  • References
  • NIV: Noninvasive Ventilation via Different Face Masks/Helmets
  • Introduction
  • History of Helmet Interface
  • Bench Studies of Helmet Interface
  • Helmet Interface in Pandemics
  • Severe Acute Respiratory Syndrome (SARS-CoV, 2002-2003)
  • Influenza A Virus (H1N1, 2009-2010)
  • Middle East Respiratory Syndrome (MERS-CoV, 2012)
  • Coronavirus Disease 2019/COVID-19 (SARS-CoV-2, 2019)
  • References
  • Humidification and Aerosol Therapy During Non-Invasive Ventilation
  • Introduction
  • Physiological Concepts
  • Humidification Devices
  • Humidification Settings
  • Factors That Effect Humidification
  • Infection Control
  • Pressure Ulcer
  • Aerosol Delivery
  • Conclusion
  • Aerosol Therapy
  • Introduction
  • Types of Aerosol Therapy
  • Factors Determining the Delivery
  • Optimum Position of Device
  • Device
  • Ventilator Settings
  • Nebulization Mode
  • Humidification and Aerosol Delivery
  • Conclusion.
  • Noninvasive Ventilation in Legionnaires' Disease
  • Introduction
  • Treatment
  • NIMV in Legionnaires' Disease
  • References
  • NIV in Tuberculosis
  • Introduction
  • Tuberculosis in Intensive Care Unit
  • Noninvasive Ventilation in Tuberculosis
  • Infection Control in the Intensive Care Unit
  • Conclusion
  • References
  • Infant Nasal Bubble Continuous Positive Airway Pressure (CPAP) in Resource-Limited Settings
  • Introduction
  • Patient Selection
  • General Indications
  • Other Medical Considerations
  • Age Recommendations
  • Equipment and Design
  • Supportive Care
  • Weaning or Discontinuation of Bubble CPAP
  • Facility Considerations
  • Conclusions
  • References
  • Part III: High Risk Infections in Pediatrics and Newborns
  • NIV-Nasal High Flow in High-Risk Pediatric Neonatology
  • Introduction
  • NIV in Newborns with Respiratory Distress
  • The Type of NIV Methods
  • Nasal Continuous Positive Airway Pressure (NCPAP)
  • Nasal Intermittent Positive Pressure Ventilation (NIPPV)
  • Heated Humidified High-Flow Nasal Oxygen Therapy (HHHFNOT)
  • Nasal High-Frequency Oscillator Ventilation (NHFOV)
  • NIV in Newborns During a Pandemic
  • Neonatal Cases in 2009 H1N1 Pandemic, 2012 SARS Outbreak, and COVID-19 Pandemic
  • Conclusion
  • References
  • NIV-Nasal High Flow in High-Risk Pediatric Infections
  • Introduction
  • Mechanism of Action of HFNO Therapy
  • Recommended Flow Setting and Cannula Size for HFNO Therapy in Pediatric Patients
  • HFNO Versus Continuous Positive Airway Pressure (CPAP) in Pediatric Sepsis
  • Safety Issues in Pediatric Patients
  • Conclusion
  • References
  • Part IV: NIV Guidelines, Protocols and Outcome, Strategies to Control Infections in Hospitals
  • Guidelines and Protocol
  • Introduction
  • NIV-Related Contagious Risk in Infective Diseases
  • What About the Risk of Transmission of Contagious During NIRT?.

Similar Items